Hospital Universitario Quironsalud Madrid

At Hospital Universitario Quironsalud Madrid, the Servicio de Neumología is running studies across key respiratory tract diseases, focusing on conditions such as chronic obstructive pulmonary disease, bronchiectasis, severe asthma, and respiratory syncytial virus prevention in vulnerable children. These trials are mainly designed to improve symptom control, reduce flare-ups, and evaluate new treatment options for people living with chronic lung disease.

• Chronic obstructive pulmonary disease and long-term control of exacerbations
• Bronchiectasis and maintenance treatment after prior study participation
• Severe asthma with eosinophilic inflammation and add-on therapy
• Respiratory syncytial virus prevention in infants and children at higher risk

This research also reflects a strong interest in practical outcomes that matter to patients, such as breathing stability, fewer hospital visits, and better day-to-day quality of life.

A major part of the site’s clinical research is centered on neoplasms, especially lung cancer, breast cancer, bladder cancer, melanoma, and a wide range of lymphomas and other blood cancers. These trials are exploring new immunotherapies, targeted approaches, and combination strategies to improve tumor control and extend survival in both newly diagnosed and previously treated disease.

• Solid tumors including lung, breast, bladder, prostate, and head and neck cancers
• Hematologic cancers such as follicular lymphoma, diffuse large B-cell lymphoma, and multiple myeloma
• Studies in relapsed or refractory disease to find better treatment options
• Trials evaluating whether new combinations can improve response and survival outcomes

The oncology portfolio at Hospital Universitario Quironsalud Madrid shows broad activity in both common and harder-to-treat cancers, with an emphasis on testing therapies that may offer more durable benefit.

The site is also involved in research on cardiovascular diseases and nutritional and metabolic diseases, including atherosclerotic cardiovascular disease, hypercholesterolemia, obesity, overweight, type 2 diabetes, and non-alcoholic steatohepatitis. These studies are aimed at preventing major cardiovascular events, improving lipid and glucose control, and understanding how metabolic disease can be managed more effectively over time.

• Prevention of heart attacks, stroke, and other major cardiovascular events
• Lowering LDL cholesterol and improving lipid-related risk
• Weight-related conditions, including obesity and overweight
• Metabolic liver disease such as non-alcoholic steatohepatitis

This area combines prevention-focused research with treatment studies for people already living with cardiometabolic risk factors.

Clinical trials at the site also cover immune system diseases and skin and connective tissue diseases, with work in atopic dermatitis, prurigo nodularis, and other inflammatory conditions. The goal is to test therapies that can better relieve itching, reduce skin inflammation, and improve visible symptoms and comfort for patients with chronic immune-mediated disease.

• Atopic dermatitis and eczema-related disease control
• Prurigo nodularis with a focus on itch relief and skin improvement
• Inflammatory conditions where symptom reduction is a key outcome
• Research on new immune-targeted treatment approaches

These studies add an important dermatology and immunology dimension to the research profile of Hospital Universitario Quironsalud Madrid.

Another active area includes nervous system diseases and musculoskeletal diseases, with studies in migraine, early Parkinson’s disease, multiple sclerosis, diabetic peripheral neuropathic pain, and knee osteoarthritis pain. These trials are generally focused on improving symptom relief, preserving function, and assessing whether new treatments can better support long-term daily living.

• Migraine treatment and safety in pediatric and adult settings
• Early Parkinson’s disease and disease-modifying research
• Multiple sclerosis with emphasis on long-term tolerability
• Neuropathic and joint pain, including diabetic nerve pain and osteoarthritis

This mix of neurological and pain-related studies broadens the site’s research beyond major organ disease into conditions that strongly affect mobility and quality of life.

The trial portfolio also includes hemic and lymphatic diseases and selected complex inflammatory disorders, such as warm autoimmune hemolytic anemia and other immune-mediated blood conditions. In addition, the site participates in studies that look at vaccine responses, infection prevention, and broader health-related questions linked to public health and metabolism.

• Autoimmune blood disorders and anemia-related outcomes
• Lymphoid and other hematologic conditions with limited treatment options
• Vaccine and infection-prevention research
• Broader studies tied to public health and metabolic processes

Together, these projects show a diverse research environment at the Hospital Universitario Quironsalud Madrid, with studies spanning chronic disease management, cancer care, immune disorders, and prevention.